NCT03419715View on ClinicalTrials.gov

Topical Bimatoprost in the Treatment of Migraine

PHASE2UnknownINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

January 5, 2018

Primary Completion Date

April 25, 2019

Study Completion Date

June 30, 2019

Conditions
Migraine DisordersHeadache Disorders
Interventions
DRUG

Bimatoprost Topical Solution

One drop of bimatoprost topical solution is applied daily to the lunula region of the fingernail bed

DRUG

Control

One drop of saline solution is applied daily to the lunula of the fingernail bed on one hand.

Trial Locations (2)

45212

CTI Clinical Trial and Consulting Services, Cincinnati

02886

Omega Medical Research, Warwick

Sponsors

Lead Sponsor

Manistee Partners
All Listed Sponsors
lead

Manistee Partners

INDUSTRY

NCT03419715 - Topical Bimatoprost in the Treatment of Migraine | Biotech Hunter | Biotech Hunter